Why eConsent Primes Studies & Patients for Success

According to a survey conducted by Florence Healthcare, 47% of research sites had adopted eConsent by December 2020, just 8 months after the WHO declared an official pandemic. By July 2021, 75% of research sites had either used it or were looking into it. In conclusion - a decentralized consent process is here to stay. Learn why Medable's Total eConsent offering is the industry-leading remote consent technology, and how it can reduce your enrolment timelines by 50%.

Related Content

Advertisement

August 2nd 2025

Understanding Access Barriers to Physician-Administered Therapies for Rheumatoid Arthritis

This whitepaper presents a structured analysis of prior authorization outcomes for RA treatments requiring medical benefit coverage. It examines real-world access barriers from the perspective of payer decision patterns, documentation requirements, site of care, and plan type. Unlike claims-based studies or survey-based research, this analysis draws from actual prior authorization cases, providing a direct window into the real-world challenges faced by prescribers and patients alike.

August 2nd 2025

Breaking Through Prior Authorization (PA) Barriers for a Leading Neurology Brand

Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.

August 2nd 2025

Strategic Interventions Drive Down Therapeutic Discontinuation Rate

Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.

August 2nd 2025

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

ConnectiveRx

August 2nd 2025

Success Guide – Marketing’s Final Mile

ACTO

August 2nd 2025

Success Guide – First Contact to Field Excellence in Pharma

ACTO

Related Content

Advertisement

August 2nd 2025

Understanding Access Barriers to Physician-Administered Therapies for Rheumatoid Arthritis

This whitepaper presents a structured analysis of prior authorization outcomes for RA treatments requiring medical benefit coverage. It examines real-world access barriers from the perspective of payer decision patterns, documentation requirements, site of care, and plan type. Unlike claims-based studies or survey-based research, this analysis draws from actual prior authorization cases, providing a direct window into the real-world challenges faced by prescribers and patients alike.

August 2nd 2025

Breaking Through Prior Authorization (PA) Barriers for a Leading Neurology Brand

Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.

August 2nd 2025

Strategic Interventions Drive Down Therapeutic Discontinuation Rate

Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.

August 2nd 2025

Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program

ConnectiveRx

August 2nd 2025

Success Guide – Marketing’s Final Mile

ACTO

August 2nd 2025

Success Guide – First Contact to Field Excellence in Pharma

ACTO